Clifton Mining Company Inc. (OTC : CFTN)
ALPINE, UT, April 12 /CNW/ - American Biotech Labs(R) (ABL), a private
company (Clifton Mining Company owns 23% of ABL) announces that they have just
appointed Dr. Gordon Pedersen as Chief Science Officer.
Dr. Gordon Pedersen is an international best-selling author. He is the
formulator of more than 150 nutritional products and is the host of the radio
show "Common Sense Medicine". He now serves as the director of the Institute
of Alternative Medicine and was nominated to chair the United States
Pharmacopoeia Review Board, Natural Products Committee. Dr. Pedersen is an
acclaimed scientist and sought after professional speaker and nutritional
Dr. Pedersen received his Doctorate degree in Toxicology with emphasis in
Virology from Utah State University, and a Master's degree in Cardiac
Rehabilitation and Wellness. Dr. Pedersen has authored a number of important
protocols in virology. Most recently, Dr. Pedersen has been a Vice President
of a multi-national company with annual sales in excess of a billion dollars.
Said Keith Moeller, "Dr. Pedersen brings a wealth of knowledge and experience
to our company not only as a leading salesman in both domestic and
international markets but also as a research scientist. We consider Dr.
Pedersen a rare find and we are very pleased to have him join our team."
Clifton trades on the U.S. OTC: (CFTN).
Note: Any statements released by Clifton Mining Company that are forward
looking are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Editors and investors are cautioned
that forward looking statements invoke risk and uncertainties that may affect
the company's business prospects and performance.
For further information:
For further information: Dr. Ken Friedman, President, at (303) 642-0659;
Keith Moeller, Vice President, at (801) 756-1414 ext. 100, or see our website